Finance

Beta
Lists
524558:BOM
Neuland Laboratories Ltd
₹18,440.00
-1.78%
(-333.60) 1D
Jul 17, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524558...
Open
₹18,867.45
High
₹18,867.45
Low
₹18,041.55
Mkt. cap
236.51B
Avg. vol.
2.72K
Volume
1.64K
Dividend
0.18%
Quarterly dividend
₹8.50
Ex-dividend date
Jul 24, 2026
P/E ratio
65.00
52-wk high
₹20,072.00
52-wk low
₹11,500.00
EPS
₹283.71
Shares outstanding
12.83M
No. of employees
2K
Open
₹18,867.45
High
₹18,867.45
Low
₹18,041.55
Mkt. cap
236.51B
Avg. vol.
2.72K
Volume
1.64K
Dividend
0.18%
Quarterly dividend
₹8.50
Ex-dividend date
Jul 24, 2026
P/E ratio
65.00
52-wk high
₹20,072.00
52-wk low
₹11,500.00
EPS
₹283.71
Shares outstanding
12.83M
No. of employees
2K
News stories
From sources across the web
About Neuland Laboratories Ltd
CEO-
Employees2.18K
Founded1984
Headquarters-
SectorPharmaceutical industry
Websiteneulandlabs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.93B
5.14B
4.40B
7.76B
Cost of goods sold
1.53B
2.30B
2.44B
3.21B
Cost of revenue
1.53B
2.30B
2.44B
3.21B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
734.65M
803.72M
888.32M
1.00B
Operating expense
1.26B
1.52B
1.43B
1.68B
Total operating expenses
2.78B
3.81B
3.86B
4.89B
Operating income
142.99M
1.33B
532.13M
2.88B
Other non operating income
78.56M
18.00M
80.52M
-229.59M
EBT including unusual items
175.70M
1.29B
544.75M
2.87B
EBT excluding unusual items
175.70M
1.29B
544.75M
2.83B
Income tax expense
36.70M
325.83M
139.04M
748.22M
Effective tax rate
20.89%
25.17%
25.52%
26.03%
Other operating expenses
318.80M
487.90M
301.24M
425.70M
Net income
139.00M
968.54M
405.72M
2.13B
Net profit margin
4.75%
18.83%
9.23%
27.40%
Earnings per share
10.83
75.49
31.62
165.76
Interest and investment income
-
-
-
100.55M
Interest expense
-45.85M
-53.67M
-67.90M
-19.54M
Net interest expenses
-45.85M
-53.67M
-67.90M
81.01M
Depreciation and amortization charges
201.90M
225.42M
239.20M
250.89M
EBITDA
291.26M
1.54B
680.40M
3.07B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer